Cargando…

Improvement of HSV-1 based amplicon vectors for a safe and long-lasting gene therapy in non-replicating cells

A key factor for developing gene therapy strategies for neurological disorders is the availability of suitable vectors. Currently, the most advanced are adeno-associated vectors that, while being safe and ensuring long-lasting transgene expression, have a very limited cargo capacity. In contrast, he...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soukupová, Marie, Zucchini, Silvia, Trempat, Pascal, Ingusci, Selene, Perrier-Biollay, Coline, Barbieri, Mario, Cattaneo, Stefano, Bettegazzi, Barbara, Falzoni, Simonetta, Berthommé, Hervé, Simonato, Michele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044385/ https://www.ncbi.nlm.nih.gov/pubmed/33869657 http://dx.doi.org/10.1016/j.omtm.2021.03.020

Ejemplares similares

Silencing Status Epilepticus-Induced BDNF Expression with Herpes Simplex Virus Type-1 Based Amplicon Vectors
por: Falcicchia, Chiara, et al.
Publicado: (2016)

Gene Therapy Tools for Brain Diseases
por: Ingusci, Selene, et al.
Publicado: (2019)

Engineered HSV vector achieves safe long-term transgene expression in the central nervous system
por: Verlengia, Gianluca, et al.
Publicado: (2017)

A Matter of Genes: The Hurdles of Gene Therapy for Epilepsy
por: Ingusci, Selene, et al.
Publicado: (2019)

Low-dose 7,8-Dihydroxyflavone Administration After Status Epilepticus Prevents Epilepsy Development
por: Guarino, Annunziata, et al.
Publicado: (2022)

NPY and Gene Therapy for Epilepsy: How, When,... and Y
por: Cattaneo, Stefano, et al.
Publicado: (2021)

A Replication-Defective Herpes Simplex Virus (HSV)-2 Vaccine, HSV529, is Safe and Well-Tolerated in Adults with or without HSV Infection and Induces Significant HSV-2-Specific Antibody Responses in HSV Seronegative Individuals
por: Dropulic, Lesia, et al.
Publicado: (2017)

Constitutive and Inducible Innate Responses in Cells Infected by HSV-1-Derived Amplicon Vectors
por: Tsitoura, Eliza, et al.
Publicado: (2010)

Induction of humoral responses to BHV-1 glycoprotein D expressed by HSV-1 amplicon vectors
por: Blanc, Andrea Maria, et al.
Publicado: (2012)

Deletion of the Virion Host Shut-off Gene Enhances Neuronal-Selective Transgene Expression from an HSV Vector Lacking Functional IE Genes
por: Miyagawa, Yoshitaka, et al.
Publicado: (2017)

Implication of sestrin3 in epilepsy and its comorbidities
por: Lovisari, Francesca, et al.
Publicado: (2020)

Developing de novo human artificial chromosomes in embryonic stem cells using HSV-1 amplicon technology
por: Moralli, Daniela, et al.
Publicado: (2015)

An HSV-1-H129 amplicon tracer system for rapid and efficient monosynaptic anterograde neural circuit tracing
por: Xiong, Feng, et al.
Publicado: (2022)

Functional Overexpression of Vomeronasal Receptors Using a Herpes Simplex Virus Type 1 (HSV-1)-Derived Amplicon
por: Stein, Benjamin, et al.
Publicado: (2016)

Co-delivery of novel bispecific and trispecific engagers by an amplicon vector augments the therapeutic effect of an HSV-based oncolytic virotherapy
por: Ravirala, Divya, et al.
Publicado: (2021)

Development and Assessment of Herpes Simplex Virus Type 1 (HSV-1) Amplicon Vectors with Sensory Neuron-Selective Promoters
por: Joussain, Charles, et al.
Publicado: (2022)

Implication of fibroblast growth factors in epileptogenesis-associated circuit rearrangements
por: Paradiso, Beatrice, et al.
Publicado: (2013)

Single dose of Glycoprotein K (gK)-deleted HSV-1 live-attenuated virus protects mice against lethal vaginal challenge with HSV-1 and HSV-2 and induces lasting T cell memory immune responses
por: Iyer, Arun V, et al.
Publicado: (2013)

HSV Replication: Triggering and Repressing STING Functionality
por: Krawczyk, Eric, et al.
Publicado: (2023)

Safe doubling of ventilator capacity: a last resort proposal for last resorts
por: Chase, J. Geoffrey, et al.
Publicado: (2020)

MicroRNA profiles in hippocampal granule cells and plasma of rats with pilocarpine-induced epilepsy – comparison with human epileptic samples
por: Roncon, Paolo, et al.
Publicado: (2015)

Human lactoferrin but not lysozyme neutralizes HSV-1 and inhibits HSV-1 replication and cell-to-cell spread
por: Välimaa, Hannamari, et al.
Publicado: (2009)

IFI16 Restricts HSV-1 Replication by Accumulating on the HSV-1 Genome, Repressing HSV-1 Gene Expression, and Directly or Indirectly Modulating Histone Modifications
por: Johnson, Karen E., et al.
Publicado: (2014)

HSV-2- and HIV-1- permissive cell lines co-infected by HSV-2 and HIV-1 co-replicate HSV-2 and HIV-1 without production of HSV-2/HIV-1 pseudotype particles
por: LeGoff, Jérôme, et al.
Publicado: (2007)

Correction: IFI16 Restricts HSV-1 Replication by Accumulating on the HSV-1 Genome, Repressing HSV-1 Gene Expression, and Directly or Indirectly Modulating Histone Modifications
por: Johnson, Karen E., et al.
Publicado: (2018)

Psoromic Acid, a Lichen-Derived Molecule, Inhibits the Replication of HSV-1 and HSV-2, and Inactivates HSV-1 DNA Polymerase: Shedding Light on Antiherpetic Properties
por: Hassan, Sherif T. S., et al.
Publicado: (2019)

Inhibition of HSV-1 Replication by Gene Editing Strategy
por: Roehm, Pamela C., et al.
Publicado: (2016)

IL-25 Enhances HSV-1 Replication by Inhibiting Filaggrin Expression, and Acts Synergistically with T(H)2 Cytokines to Enhance HSV-1 Replication
por: Kim, Byung Eui, et al.
Publicado: (2013)

Immunogenicity, Protective Efficacy, and Non-Replicative Status of the HSV-2 Vaccine Candidate HSV529 in Mice and Guinea Pigs
por: Bernard, Marie-Clotilde, et al.
Publicado: (2015)

FasL and FADD delivery by a glioma-specific and cell cycle-dependent HSV-1 amplicon virus enhanced apoptosis in primary human brain tumors
por: Ho, Ivy A, et al.
Publicado: (2010)

Detecting adenosine triphosphate in the pericellular space
por: Falzoni, Simonetta, et al.
Publicado: (2013)

Worldwide circulation of HSV-2 × HSV-1 recombinant strains
por: Koelle, David M., et al.
Publicado: (2017)

Generation of a Dual-Target, Safe, Inexpensive Microbicide that Protects Against HIV-1 and HSV-2 Disease
por: Farr Zuend, Christina, et al.
Publicado: (2018)

Negative epidemiological association between HSV-1 and HSV-2 infections
por: Nasrallah, Gheyath K., et al.
Publicado: (2019)

HSV-1 miR-H6 Inhibits HSV-1 Replication and IL-6 Expression in Human Corneal Epithelial Cells In Vitro
por: Duan, Fang, et al.
Publicado: (2012)

Short hairpin-loop-structured oligodeoxynucleotides reduce HSV-1 replication
por: Falkenhagen, Alexander, et al.
Publicado: (2009)

HSV-1 DNA Replication—Coordinated Regulation by Viral and Cellular Factors
por: Packard, Jessica E., et al.
Publicado: (2021)

Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women
por: Gilbert, Peter B., et al.
Publicado: (2017)

eIF4B phosphorylation at Ser504 links synaptic activity with protein translation in physiology and pathology
por: Bettegazzi, Barbara, et al.
Publicado: (2017)

In vitro Inactivation of Latent HSV by Targeted Mutagenesis Using an HSV-specific Homing Endonuclease
por: Aubert, Martine, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_v51navb8c735jgfsrejlbd311l